These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 24106234)
1. Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure. Aden B; Nosyk B; Wittenberg E; Schackman BR Med Decis Making; 2014 Aug; 34(6):800-8. PubMed ID: 24106234 [TBL] [Abstract][Full Text] [Related]
2. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals. Gillis J; Cooper C; Rourke S; Rueda S; O'Brien K; Collins E; Rachlis A; Hart TA; Raboud J; Qual Life Res; 2013 Sep; 22(7):1525-35. PubMed ID: 23070749 [TBL] [Abstract][Full Text] [Related]
3. Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women. Richardson JL; Nowicki M; Danley K; Martin EM; Cohen MH; Gonzalez R; Vassileva J; Levine AM AIDS; 2005 Oct; 19(15):1659-67. PubMed ID: 16184036 [TBL] [Abstract][Full Text] [Related]
4. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727 [TBL] [Abstract][Full Text] [Related]
5. Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy). Venturini A; Cenderello G; Di Biagio A; Giannini B; Ameri M; Giacomini M; Montefiori M; Setti M; Mazzarello G; Merlano C; Orcamo P; Viscoli C; Cassola G AIDS Care; 2017 Nov; 29(11):1373-1377. PubMed ID: 28150510 [TBL] [Abstract][Full Text] [Related]
6. Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. Baum MK; Jayaweera DT; Duan R; Sales S; Lai S; Rafie C; Regev A; Page JB; Berkman R; Campa A J Addict Dis; 2008; 27(2):37-48. PubMed ID: 18681190 [TBL] [Abstract][Full Text] [Related]
7. Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment. Aden B; Dunning A; Nosyk B; Wittenberg E; Bray JW; Schackman BR J Acquir Immune Defic Syndr; 2015 Nov; 70(3):304-10. PubMed ID: 26218410 [TBL] [Abstract][Full Text] [Related]
8. Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast. Mwatelah RS; Lwembe RM; Osman S; Ogutu BR; Aman R; Kitawi RC; Wangai LN; Oloo FA; Kokwaro GO; Ochieng W PLoS One; 2015; 10(7):e0132287. PubMed ID: 26208212 [TBL] [Abstract][Full Text] [Related]
9. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy. Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598 [TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in HIV-infected patients: the role of substance use. Korthuis PT; Zephyrin LC; Fleishman JA; Saha S; Josephs JS; McGrath MM; Hellinger J; Gebo KA; AIDS Patient Care STDS; 2008 Nov; 22(11):859-67. PubMed ID: 19025480 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival. Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and patterns of illicit drug use in people with human immunodeficiency virus infection in Korea. Lee SO; Lee JE; Lee S; Lee SH; Kang JS PLoS One; 2021; 16(4):e0249361. PubMed ID: 33793637 [TBL] [Abstract][Full Text] [Related]
13. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status. Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil. da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795 [TBL] [Abstract][Full Text] [Related]
15. Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview project. Campsmith ML; Nakashima AK; Davidson AJ Health Qual Life Outcomes; 2003 Apr; 1():12. PubMed ID: 12773200 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and progression of HIV disease. Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434 [TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and associated factors in people with HIV: an Irish cohort study. George S; Bergin C; Clarke S; Courtney G; Codd MB Health Qual Life Outcomes; 2016 Aug; 14(1):115. PubMed ID: 27495166 [TBL] [Abstract][Full Text] [Related]
19. Illicit drug use and HIV treatment outcomes in a US cohort. Cofrancesco J; Scherzer R; Tien PC; Gibert CL; Southwell H; Sidney S; Dobs A; Grunfeld C AIDS; 2008 Jan; 22(3):357-65. PubMed ID: 18195562 [TBL] [Abstract][Full Text] [Related]